Avoro Capital Advisors LLC Autolus Therapeutics PLC Transaction History
Avoro Capital Advisors LLC
- $6.86 Billion
- Q4 2024
A detailed history of Avoro Capital Advisors LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 9,910,642 shares of AUTL stock, worth $19.3 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
9,910,642
Previous 12,345,678
19.72%
Holding current value
$19.3 Million
Previous $44.8 Million
48.03%
% of portfolio
0.34%
Previous 0.67%
Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
112Shares Held
156MCall Options Held
0Put Options Held
116K-
Wellington Management Group LLP Boston, MA25.3MShares$49.4 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$39.9 Million0.24% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$32.4 Million73.83% of portfolio
-
Deep Track Capital, LP Greenwich, CT14.2MShares$27.7 Million1.47% of portfolio
-
Armistice Capital, LLC New York, NY9.2MShares$17.9 Million0.31% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $177M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...